HIV-HBV coinfection among South African patients receiving antiretroviral therapy.
about
High seroprevalence of HBV and HCV infection in HIV-infected adults in Kigali, Rwanda.Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya.Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial.HIV, Hepatitis B, and Hepatitis C in Zambia.Hepatitis B virus sub-genotype A1 infection is characterized by high replication levels and rapid emergence of drug resistance in HIV-positive adults receiving first-line antiretroviral therapy in MalawiSlow CD4+ T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana.Current treatment of hepatitis B virus infections.Seroprevalence of Hepatitis B and Delta viruses among HIV infected population attending Antiretroviral clinic in selected health facilities in Abuja Nigeria.HBV infection in untreated HIV-infected adults in Maputo, Mozambique.HBV influence on Response to Antiretroviral Therapy in Horizontally HIV-HBV Coinfected Patient during Early Childhood.Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial.HBV and HIV viral load but not microbial translocation or immune activation are associated with liver fibrosis among patients in South Africa.
P2860
Q34743962-EAE6E150-E82B-4A70-AD8B-DE9D51E229EFQ34982182-A76FC69C-2B4F-49B7-9017-06B0FDF6D658Q35063655-453CDC8B-B1A7-426C-81F8-5A2185582233Q35183973-CC016205-7316-4813-A522-E223F74A267AQ36293979-A40352EE-6D19-4169-93F0-3E3A9641C45CQ37375386-1E06EBFC-C52A-40B5-82B9-225CF3500ACAQ38553056-37C3D4AA-9DEA-431E-B94E-741EB21F06BEQ38602272-5FCDB9CE-821F-4DF6-BFA0-A3EA2729F383Q38651617-38036EF2-9FC2-421E-85CE-AE374E80652CQ40187537-3374A102-788B-4820-A904-E863EE88C210Q50348041-45FA9ABA-2C26-4D97-81FE-558E875859E3Q54988709-9E9CADDB-7E21-46EC-B2EE-741BA047E9E2
P2860
HIV-HBV coinfection among South African patients receiving antiretroviral therapy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
HIV-HBV coinfection among South African patients receiving antiretroviral therapy.
@ast
HIV-HBV coinfection among South African patients receiving antiretroviral therapy.
@en
HIV-HBV coinfection among South African patients receiving antiretroviral therapy.
@nl
type
label
HIV-HBV coinfection among South African patients receiving antiretroviral therapy.
@ast
HIV-HBV coinfection among South African patients receiving antiretroviral therapy.
@en
HIV-HBV coinfection among South African patients receiving antiretroviral therapy.
@nl
prefLabel
HIV-HBV coinfection among South African patients receiving antiretroviral therapy.
@ast
HIV-HBV coinfection among South African patients receiving antiretroviral therapy.
@en
HIV-HBV coinfection among South African patients receiving antiretroviral therapy.
@nl
P2093
P2860
P50
P356
P1433
P1476
HIV-HBV coinfection among South African patients receiving antiretroviral therapy.
@en
P2093
Anne Reyneke
Cindy Firnhaber
Doreen Schulze
P2860
P304
P356
10.3851/IMP1494
P433
P577
2010-01-01T00:00:00Z